Consistently, previous studies showed that β5‐integrin is commonly expressed in various tumors, including NSCLC.[24] Our data also indicated that a high percentage of pericyte‐IL32 positive blood vessels correlated with poor progression‐free survival in our patient cohort (Figure 1M). Here, IL32 is linked to non-small cell lung carcinoma.